Lodonal Clinical Trial

Lodonal Clinical Trial

The Bridging Trial has met all parameters of the Nigerian Trial Clinical Research Health [ NTCR] & Nigerian Health Research Ethics Committee [ NHREC] as confirmed on their official website and stated below: 89519615

 

A Bridging study to Evaluate the Effects of LODONAL as an Immune-System Regulating Agent in Subjects in Which their Immune System is Compromised. The primary objective of this clinical trial is to confirm that LODONAL has a beneficial effect on the immune system of patients in Nigeria with a compromised immune system (refer to Inclusion/Exclusion Criteria). This will be determined by: The number of subjects with CD4 count stabilization (less than 10% change from baseline mean values) or 25% increase in CD4 counts on LODONAL compared to observation group from baseline to Days 30, 60 and 90. 2015-03-31

More informtion cn be found on the Nigeria Clincal Trial Registry